Immunopharmacology in Vernal Keratoconjunctivitis: Current and Future Perspectives

被引:22
作者
Chigbu, DeGaulle, I [1 ]
Labib, Bisant A. [1 ]
机构
[1] Salus Univ, Penn Coll Optometry, 8360 Old York Rd, Elkins Pk, PA 19027 USA
关键词
vernal keratoconjunctivitis; clinicopathologic correlations; immunomodulators; immunobiologics; pharmacotherapy; CYCLOSPORINE-A; 0.05-PERCENT; DRY EYE DISEASE; TOPICAL CYCLOSPORINE; MAST-CELL; ALLERGIC CONJUNCTIVITIS; ATOPIC-DERMATITIS; DENDRITIC CELLS; OCULAR SURFACE; SHIELD ULCERS; CASE SERIES;
D O I
10.3390/ph14070658
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Vernal keratoconjunctivitis (VKC) is a complex and chronic, multifactorial Th2 cell-mediated chronic ocular surface inflammatory condition that typically affects predominantly male children in hot or warm climates. The primary symptom is intense ocular pruritus, often significant enough to affect activities of daily living. Clinical features differ from simple forms of allergic conjunctivitis in that they are more-or-less confined to the superior tarsus and limbus. There is also a risk of corneal involvement, which leads to irreversible vision loss in approximately 6% of patients. Right now, there is no standardized treatment protocol, and many of the currently available options are not effective in severe and recurrent cases. As such, it is imperative to understand this complex allergic immune response in order to identify future therapeutic targets. This review will focus on potential drug targets in VKC, with particular emphasis on immunomodulators and immunobiologic agents.
引用
收藏
页数:22
相关论文
共 50 条
[31]   Cyclosporine A and autologous serum efficacy for treatment of vernal keratoconjunctivitis [J].
Esmail, Ahmed ;
Hashem, Ahmed O. ;
Elashri, Mohammed ;
Ibrahim, Mohamed Ahmed Hafez .
JOURNAL OF THE EGYPTIAN OPHTHALMOLOGICAL SOCIETY, 2024, 117 (02) :108-118
[32]   Vernal Keratoconjunctivitis: Immunopathological Insights and Therapeutic Applications of Immunomodulators [J].
Hehar, Navpreet K. ;
Chigbu, DeGaulle I. .
LIFE-BASEL, 2024, 14 (03)
[33]   Efficacy and safety of topical cyclosporine A 0.05% in vernal keratoconjunctivitis [J].
Yucel, Ozlem Eski ;
Ulus, Nihal Demir .
SINGAPORE MEDICAL JOURNAL, 2016, 57 (09) :507-510
[34]   Diagnostic criteria of chronic conjunctivitis: atopic keratoconjunctivitis and vernal keratoconjunctivitis [J].
Leonardi, Andrea ;
Righetti, Giuseppe ;
Giovannini, Giulia ;
De Marchi, Vittorio ;
Occhiuto, Matteo .
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 23 (05) :390-396
[35]   An Update on the Therapeutic Approach to Vernal Keratoconjunctivitis [J].
Esposito, Susanna ;
Fior, Giulia ;
Mori, Alessandro ;
Osnaghi, Silvia ;
Ghiglioni, Daniele .
PEDIATRIC DRUGS, 2016, 18 (05) :347-355
[36]   Vernal keratoconjunctivitis: The burden of being allergic [J].
Artesani, Maria Cristina ;
Esposito, Mariacristina ;
Buzzonetti, Luca ;
Di Nardo, Giovanni ;
Fiocchi, Alessandro Giovanni ;
Mennini, Maurizio .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: GLOBAL, 2025, 4 (02)
[37]   Vernal keratoconjunctivitis: an update [J].
De Smedt, Stefan ;
Wildner, Gerhild ;
Kestelyn, Philippe .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2013, 97 (01) :9-14
[38]   Vernal Keratoconjunctivitis- A Survey on Practice Patterns and Perspectives of Indian Ophthalmologists [J].
Chandranna, Shwetha N. ;
Balagopal, Ratthiga ;
Achappa, Santosh ;
Kumar, Kaushal .
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (04)
[39]   An essential role for dendritic cells in vernal keratoconjunctivitis: analysis by laser scanning confocal microscopy [J].
Liu, M. ;
Gao, H. ;
Wang, T. ;
Wang, S. ;
Li, S. ;
Shi, W. .
CLINICAL AND EXPERIMENTAL ALLERGY, 2014, 44 (03) :362-370
[40]   An observational study on the presence of perilimbal conjunctival pigmentation in vernal keratoconjunctivitis [J].
Dubbaka, Srujana ;
Agrawal, Mohini ;
Sati, Alok ;
Vats, Sumedha ;
Mahajan, Saurabh .
INDIAN JOURNAL OF OPHTHALMOLOGY, 2023, 71 (05) :1816-1821